Press Releases 2013
Press Releases 2012
Press Releases 2011
Press Releases 2010
Press Releases 2009
Press Releases 2008
Press Releases 2007
Press Releases 2006
Press Releases 2005
Press Releases 2004
Press Releases 2003
11.05.10
Ironwood Pharmaceuticals Announces Upcoming Presentation at Credit Suisse 2010 Healthcare Conference
11.04.10
Ironwood Pharmaceuticals Provides Third Quarter 2010 Investor Update
11.01.10
Ironwood and Forest Announce Positive Linaclotide Results from Second Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation
- Top-line Results Show Trial Met All Primary and Secondary Endpoints
11.01.10
Almirall and Ironwood Announce Positive Results from the Second Phase 3 Trial of Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
- Top-line results from the second of two Phase 3 linaclotide trials show that both co-primary and all secondary efficacy endpoints were met
11.01.10
Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results
09.13.10
Almirall and Ironwood Announce Positive Results from a Phase 3 Trial with Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
- Top-line results of the Phase 3 study with linaclotide show that both primary and main secondary endpoints were met and was well tolerated.
09.13.10
Ironwood and Forest Announce Positive Linaclotide Results from Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation
- Top-line Results Show Trial Met All Primary and Secondary Endpoints
09.13.10
Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results
09.09.10
Ironwood Pharmaceuticals Announces Upcoming Presentation at Morgan Stanley Global Healthcare Conference
08.05.10
Ironwood Pharmaceuticals Provides Second Quarter 2010 Investor Update
08.02.10
Ironwood Pharmaceuticals Announces Second Quarter 2010 Investor Update Call
07.28.10
Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010
05.26.10
Ironwood Pharmaceuticals Announces Participation in J.P. Morgan Biotech CEO/CFO Conference Call
05.11.10
Ironwood Pharmaceuticals Provides First Quarter 2010 Investor Update
05.07.10
Ironwood Pharmaceuticals Announces First Quarter 2010 Investor Update Call and Upcoming Presentation at Bank of America Merrill Lynch 2010 Health Care Conference
05.03.10
Ironwood and Forest Present Positive Linaclotide Results From Two Pivotal Phase 3 Trials In Patients With Chronic Constipation
- Data Presented at DDW Demonstrate Trials Met Primary and All Secondary Endpoints
04.26.10
Ironwood and Forest to Present Linaclotide Phase 3 Chronic Constipation Data
- Data to be presented at Digestive Disease Week 2010
03.30.10
Ironwood Pharmaceuticals Files Annual Report on Form 10-K
02.16.10
Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals Initial Public Offering
Lisa Buffington
VP, Corporate Communications
617.374.5103
lbuffington@ironwoodpharma.com
Copyright © 2013, Ironwood Pharmaceuticals, Inc.
All Rights Reserved
|
Privacy Policy
|
Terms of Service
|
Site Design
